EcoDrugPlus

Cf Transmembrane Conductance Regulator

Ensembl ID : ENSSLDG00000009217
Gene Symbol: CFTR
3 Cross references
214 Possible Orthologues:

Chrna7-Fam7a Fusion Protein-Like

Ensembl ID : ENSSLDG00000000127
Gene Symbol: LOC111670128
3 Cross references
205 Possible Orthologues:

D(4) Dopamine Receptor-Like

Ensembl ID : ENSSLDG00000024360
Gene Symbol: LOC111656652
3 Cross references
181 Possible Orthologues:

Dna Methyltransferase 1

Ensembl ID : ENSSLDG00000014902
Gene Symbol: DNMT1
3 Cross references
210 Possible Orthologues:

Dna Topoisomerase 1-Like

Ensembl ID : ENSSLDG00000011470
Gene Symbol: LOC111649260
3 Cross references
207 Possible Orthologues:

Dna Topoisomerase I

Ensembl ID : ENSSLDG00000025343
Gene Symbol: TOP1
1 Cross references
198 Possible Orthologues:

Dna Topoisomerase Ii Alpha

Ensembl ID : ENSSLDG00000021789
Gene Symbol: TOP2A
3 Cross references
209 Possible Orthologues:

E-Selectin-Like

Ensembl ID : ENSSLDG00000015987
Gene Symbol: LOC111656306
2 Cross references
182 Possible Orthologues:

Emap Like 4

Ensembl ID : ENSSLDG00000001047
Gene Symbol: EML4
2 Cross references
207 Possible Orthologues:

Eph Receptor A3

Ensembl ID : ENSSLDG00000023941
Gene Symbol: EPHA3
3 Cross references
210 Possible Orthologues:

F2r Like Thrombin Or Trypsin Receptor 3

Ensembl ID : ENSSLDG00000017115
Gene Symbol: F2RL3
4 Cross references
195 Possible Orthologues:

Fau Ubiquitin Like And Ribosomal Protein S30 Fusion

Ensembl ID : ENSSLDG00000001079
Gene Symbol: FAU
3 Cross references
299 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).